Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Sitagliptin + Metformin
Janumet
Not routinely available
SMC (627/10)
29/03/2023
Indication
In combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.
Therapeutic Area
Endocrine system
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
50mg/1000mg film-coated tablet
Comments
-
Link to Advice
Advice Published
09/08/2010
SMC Submission Type
Abbreviated
SMC Status
Accepted